Key stats
About iShares Global Healthcare ETF
Home page
Inception date
Nov 13, 2001
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
IXJ offers marketlike exposure to global pharmaceutical, biotechnology, and medical device companies. The fund pulls from the S&P Global 1200 universe, which effectively screens out small-caps, giving the fund a large-cap tilt compared to our benchmark. Aside from that, geographic and sector weights look neutral and make it a viable entry-point to global healthcare. BlackRock Fund Advisors uses a sampling approach to indexing. This means the fund may not hold all the stocks of the underlying index but will hold securities that collectively have the same investment profile. Stocks within IXJ are selected and weighted by float-adjusted market-cap. The index is rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks99.81%
Health Technology85.39%
Health Services11.44%
Distribution Services2.66%
Commercial Services0.23%
Technology Services0.09%
Bonds, Cash & Other0.19%
Cash0.19%
Stock breakdown by region
North America67.86%
Europe25.59%
Asia4.74%
Oceania1.72%
Latin America0.10%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
IXJ invests in stocks. The fund's major sectors are Health Technology, with 85.39% stocks, and Health Services, with 11.44% of the basket. The assets are mostly located in the North America region.
IXJ top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 8.69% and 5.31% of the portfolio correspondingly.
IXJ last dividends amounted to 0.62 USD. Six months before that, the issuer paid 0.67 USD in dividends, which shows a 8.92% decrease.
IXJ assets under management is 3.73 B USD. It's fallen 0.08% over the last month.
IXJ fund flows account for 37.02 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, IXJ pays dividends to its holders with the dividend yield of 1.50%. The last dividend (Dec 20, 2024) amounted to 0.62 USD. The dividends are paid semi-annually.
IXJ shares are issued by BlackRock, Inc. under the brand iShares. The ETF was launched on Nov 13, 2001, and its management style is Passive.
IXJ expense ratio is 0.41% meaning you'd have to pay 0.41% of your investment to help manage the fund.
IXJ follows the S&P Global 1200 / Health Care -SEC. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
IXJ invests in stocks.
IXJ price has fallen by −2.31% over the last month, and its yearly performance shows a −7.32% decrease. See more dynamics on IXJ price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −3.02% over the last month, showed a −8.36% decrease in three-month performance and has decreased by −6.22% in a year.
NAV returns, another gauge of an ETF dynamics, have fallen by −3.02% over the last month, showed a −8.36% decrease in three-month performance and has decreased by −6.22% in a year.
IXJ trades at a premium (0.06%) meaning the ETF is trading at a higher price than the calculated NAV.